Spyre Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $608.5M
Liabilities Breakdown FY2024
Total Liabilities: $90.7M
Asset Breakdown
Total Assets: $608.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $89.4M | 14.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $519.1M | 85.3% |
Liabilities Breakdown
Total Liabilities: $90.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $90.7M | 100.0% |